Literature DB >> 16557934

Protection against pneumococcal infection by a ribosomal preparation.

H C Thompson1, I S Snyder.   

Abstract

A subcellular extract prepared from nonencapsulated Diplococcus pneumoniae type 3 protected mice against a subsequent challenge with virulent D. pneumoniae types 1, 2, 3, and 7. Potency ratios ranged from 25 (type 3) to >1,175 (type 1). The immunity induced in mice by this preparation was best obtained by intraperitoneal inoculation followed by intravenous challenge. Mice immunized in this manner were protected up to 12 weeks and could withstand a challenge of several hundred LD(50). The protection was destroyed by treatment of the preparation with ribonuclease and was decreased by treatment with protease. The preparation consisted of 60.5% ribonucleic acid, 29.1% protein, 6.3% deoxyribonucleic acid, and 4.0% hexose. Ultracentrifugation studies indicated that this extract had five constituents which are compatible with ribosomal material.

Entities:  

Year:  1971        PMID: 16557934      PMCID: PMC416101          DOI: 10.1128/iai.3.1.16-23.1971

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  The use of spiral loops in serological and virological micro-methods.

Authors:  G TAKATSY
Journal:  Acta Microbiol Acad Sci Hung       Date:  1955

2.  Nucleotide metabolism. II. Chromatographic separation of acid-soluble nucleotides.

Authors:  R B HURLBERT; H SCHMITZ; A F BRUMM; V R POTTER
Journal:  J Biol Chem       Date:  1954-07       Impact factor: 5.157

3.  Brevity of the inductive phase in the immune response of mice to capsular polysaccharide antigens.

Authors:  P J Baker; M Landy
Journal:  J Immunol       Date:  1967-10       Impact factor: 5.422

4.  The role of immune and natural specific antibodies in immunologic paralysis and immunity of mice to pneumococcal polysaccharide type 3.

Authors:  R Kerman; D Segre; W L Myers
Journal:  J Immunol       Date:  1970-03       Impact factor: 5.422

5.  Studies on macrophage RNA involved in antibody production.

Authors:  A A Gottlieb; V R Glisin; P Doty
Journal:  Proc Natl Acad Sci U S A       Date:  1967-06       Impact factor: 11.205

6.  Isolation and partial characterization of an immunogenic moiety obtained from Salmonella typhimurium.

Authors:  M R Venneman; N J Bigley
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490

7.  Preparation of highly immunogenic ribosomal fractions of Mycobacterium tuberculosis by use of sodium dodecyl sulfate.

Authors:  A S Youmans; G P Youmans
Journal:  J Bacteriol       Date:  1966-06       Impact factor: 3.490

8.  Effect of trypsin and ribonuclease on the immunogenic activity of ribosomes and ribonucleic acid isolated from Mycobacterium tuberculosis.

Authors:  A S Youmans; G P Youmans
Journal:  J Bacteriol       Date:  1966-06       Impact factor: 3.490

9.  IMMUNOGENIC ACTIVITY OF A RIBOSOMAL FRACTION OBTAINED FROM MYCOBACTERIUM TUBERCULOSIS.

Authors:  A S YOUMANS; G P YOUMANS
Journal:  J Bacteriol       Date:  1965-05       Impact factor: 3.490

10.  Immunogenicity of Ribonucleic Acid Preparations Obtained from Salmonella typhimurium.

Authors:  M R Venneman; N J Bigley; L J Berry
Journal:  Infect Immun       Date:  1970-06       Impact factor: 3.441

View more
  40 in total

1.  Biological properties of an immunogenic pneumococcal subcellular preparation.

Authors:  H C Thompson; T K Eisenstein
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

2.  Evidence for an extrinsic immunogen in effective ribosomal vaccines from Salmonella typhimurium.

Authors:  P Hoops; N E Prather; J Berry; J M Ravel
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

3.  Brucella ribosomal protein L7/L12 is a major component in the antigenicity of brucellin INRA for delayed-type hypersensitivity in brucella-sensitized guinea pigs.

Authors:  G Bachrach; M Banai; S Bardenstein; G Hoida; A Genizi; H Bercovier
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

4.  Ribosomal vaccines. II. Specificity of the immune response to ribosomal ribonucleic acid and protein isolated from Salmonella typhimurium.

Authors:  W Johnson
Journal:  Infect Immun       Date:  1973-09       Impact factor: 3.441

5.  Gonococcal ribosomes as skin test antigens. I. Preliminary tests of sensitivity and specificity.

Authors:  W L Koostra; R C Judd; R E Baker
Journal:  Br J Vener Dis       Date:  1976-02

6.  Gonococcal ribosomes as skin test antigens. II. Precision Of the Method, Attempts To Identify The Ribosomal Antigen, and Correlation with The Macrophage Migration Inhibition test.

Authors:  R C Judd; W L Koostra
Journal:  Br J Vener Dis       Date:  1976-02

7.  Cell-mediated immunity to Vibrio cholerae with ribonucleic acid-protein fractions of V. cholerae L-form lysates.

Authors:  S C Agarwal; T Sundararaj
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

8.  Immunogenicity of ribosomal vaccines isolated from group A, type 14 Streptococcus pyogenes.

Authors:  W O Schalla; W Johnson
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

9.  Capsular serotypic specificity of the protection conferred on mice by Klebsiella pneumoniae ribosomal preparations.

Authors:  M Riottot; J M Fournier; J Pillot
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

10.  Ribonuclease-sensitive ribosomal vaccines.

Authors:  R Gonggrijp; A C Antonissen; J F van den Bosch; C P van Boven
Journal:  Antonie Van Leeuwenhoek       Date:  1984       Impact factor: 2.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.